维普中文期刊产品整合服务
51篇 您的检索式:作者名="Kau SW"
    题名 作者 年代 出处 被引量
1Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors 显示文摘Guarneri V Broglio K Kau SW 2006J Clin Oncol2006,24,7:1
2Prognostic value of initial clinical disease stage after achieving pathological complete re- sponse 显示文摘Dawood S Broglio K Kau SW 2008Oncologist2008,13,1:1
3Women age < or = 35 years with primary breast carcinoma: disease features at presentation 显示文摘Gonzalez-Angulo AM Broglio K Kau SW 2005Cancer2005,103,12:1
4Triple receptor-negative breast cancer:the effect of race on response to primary systemic treatment and survival outcomes显示文摘Dawood S Broglio K Kau SW 2009J Clin Oncol2009,27,:1
5Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors显示文摘 Broglio K Kau SW 2006J Clin Oncol2006,24,:1
6Inclusion of taxanes,particularly weekly paclitaxel,in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers显示文摘Mazouni C Kau SW Frye D 2007Ann Oncol2007,18,5:1
7Thyroid hormone and breast carcinoma:primary hypothyroidism is associated with a reduced in- cidence of primary breast carcinoma显示文摘CfistofaniUi M Yamamura Y Kau SW 2005Cancer2005,103,6:1
8Triple receptornegative breast cancer:the effect of race on response to primary systemic treatment and survival outcomes显示文摘Dawood S Broglio K Kau SW 2009J Clin Oncol2009,27,2:1
9Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors显示文摘Guarneri V Broglio K Kau SW 2006J Clin Oneol2006,24,7:1
10Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors显示文摘Guarneri V Broglio K Kau SW 2006J Clin Oncol2006,24,:1
11Women age < or =35 years with primary breast carcinoma:disease features at presentation显示文摘Gonzalez-Angulo AM Broglio K Kau SW 2005Cancer2005,103,12:1
12Prognostic value pathologic complete response after primary chemotheraphy in relation to hor- mone receptor status and other factors显示文摘Guarneri V Broglio K Kau SW 2006J Clin Onco12006,24,7:1
13Triple receptor-negative breast cancer:the effect of race on response to primary systemic treatment and survival outcomes显示文摘Dawood S Broglio K Kau SW 2009J Clin Oncol2009,27,2:1
14Thyroid hormone and breas-t carcinoma:primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma显示文摘Cristofanilli M Yamamura Y Kau SW 2005Cancer2005,103,6:1
15Prognostic value of path-ologic complete response after primary chemotherapy in relation to hormone receptor status and other factors显示文摘Guarneri V Broglio K Kau SW 2006J Clin Oncol2006,24,7:1
16Thyroid hormone and breast carcinoma: primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma 显示文摘CristofaniUi M Yamamura Y Kau SW 2005Cancer2005,103,6:1
17Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors显示文摘Guarneri V Broglio K Kau SW 2006J Clin Oncol2006,24,7:1
18Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy 显示文摘Er O Frye DK Kau SW 2008Cancer J2008,14,1:1
19Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors 显示文摘Guameri V Broglio K Kau SW 2006J Clin 0ncol2006,24,:1
20Docetaxel for platinum refractory non-small cell lung cancer:Comparison of phase Ⅱ results to historical control显示文摘Fossella Fv Lee Js Kau SW 1997proc Am soc clin Oncol1997,16,2:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费